Imugene HER-Vaxx Immunotherapy Patent Granted in Japan

• Core Japanese patent granted in major HER2 positive gastric cancer market • Patent provides method of composition and method of use protection to 2036 company today announced it has received a Notice of Grant from the Japanese Patent Office for Patent Application number 2018-505505 which protects its HER-Vaxx immunotherapy, currently in development for HER2 positive gastric cancer. The patent ti